The company’s products range from vaccines and oncology to animal health. A large portion of Merck & Co.’s revenues are generated from oncology, diabetes and vaccine products. As a company Merck & Co. has one of the highest numbers of approved drugs, spending significant amounts on research and development. In recent years, two of its most important products are targeting chronic diseases that plague society. Januvia (sitagliptin) is one of the best-selling diabetes drugs globally and is popular as it does not cause weight gain. The drug generated some 3.5 billion U.S. dollars in revenue in 2019.
Merck & Co. is an international company, generating more than half of its revenues outside the United States. As one of the largest pharmaceutical companies in the world, Merck & Co. had some 71,000 employees in 2019, spread over 100 countries. The company had total assets accounting for 84 billion U.S. dollars in the same year.